Malaria Falciparum MSP1 Recombinant
Merozoite surface antigen is a protein located on the outside of the merozoite, playing an imperative role in immune reaction. About 55% cases of malaria are infected by Plasmodium falciparum (Pf). Pf MSP1 has to be used with Plasmodium vivax (Pv) together for ELISA and rapid diagnostic test, Plasmodium falciparum and vivax infection takes about 95% of Plasmodium caused infection.
Recombinant Malaria Falciparum MSP1 produced in E.coli, is a 62kDa protein fused to a GST tag at N-terminus and purified by proprietary chromatographic technique.
Malaria Vivax MSP1 Recombinant
Merozoite surface antigen is a protein located on the outside of the merozoite, playing an imperative role in immune reaction. About 45% cases of malaria are infected by Plasmodium vivax (Pv). Pv. MSP1 has to be used with Plasmodium falciparum (Pf) together for ELISA and rapid diagnostic test, Plasmodium falciparum and vivax infection takes about 95% of Plasmodium caused infection.
Recombinant Malaria Vivax MSP1 produced in E.coli and fused to a His tag was purified by proprietary chromatographic technique.
Plasmodium Falciparum HSP70 Recombinant
Malaria is a life-threatening disease caused by parasites of the genus Plasmodium. It is transmitted to humans through the bites of infected female Anopheles mosquitoes . There are five species of Plasmodium that cause malaria in humans: P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi . Among these, P. falciparum and P. vivax pose the greatest threat .
Key Biological Properties: The Plasmodium parasites are unicellular protozoans that undergo complex life cycles involving both human and mosquito hosts . They exhibit remarkable genetic flexibility, allowing them to adapt to environmental changes and develop resistance to treatments .
Expression Patterns and Tissue Distribution: The parasites initially infect liver cells, where they mature and reproduce. They then invade red blood cells, leading to the clinical symptoms of malaria . The tissue distribution is primarily in the liver and red blood cells .
Primary Biological Functions: The primary function of Plasmodium parasites is to reproduce and spread within the host. They achieve this by invading and multiplying within liver cells and red blood cells .
Role in Immune Responses and Pathogen Recognition: The parasites have evolved mechanisms to evade the host’s immune system, including altering their surface proteins to avoid detection . This immune evasion is crucial for their survival and proliferation within the host .
Mechanisms with Other Molecules and Cells: Plasmodium parasites interact with various host molecules and cells during their life cycle. For example, they bind to receptors on liver cells to gain entry and later invade red blood cells by binding to specific surface proteins .
Binding Partners and Downstream Signaling Cascades: The parasites utilize a range of binding partners, including host cell receptors and proteins, to facilitate their entry and survival within host cells . These interactions trigger downstream signaling cascades that promote parasite development and replication .
Regulatory Mechanisms Controlling Expression and Activity: The expression and activity of Plasmodium genes are tightly regulated by various mechanisms, including transcriptional regulation and post-translational modifications . Epigenetic modifications, such as histone modifications and DNA methylation, play a significant role in controlling gene expression .
Transcriptional Regulation and Post-Translational Modifications: Specific transcription factors and regulatory proteins modulate the expression of key genes involved in the parasite’s life cycle . Post-translational modifications, such as phosphorylation and ubiquitination, further regulate protein activity and stability .
Diagnostic Tools: Advances in diagnostic tools, such as rapid diagnostic tests (RDTs) and polymerase chain reaction (PCR) assays, have improved the detection and diagnosis of malaria . These tools are crucial for timely and accurate diagnosis, enabling effective treatment and control of the disease .
Therapeutic Strategies: The development of antimalarial drugs, including artemisinin-based combination therapies (ACTs), has significantly improved malaria treatment . Ongoing research aims to discover new drugs with novel mechanisms of action to combat drug-resistant strains .
Role Throughout the Life Cycle: The Plasmodium parasites undergo several stages in their life cycle, including the liver stage, blood stage, and mosquito stage . During the liver stage, the parasites mature and multiply within liver cells. In the blood stage, they invade red blood cells, leading to the clinical symptoms of malaria . The mosquito stage involves the development and transmission of the parasites through mosquito bites .
From Development to Aging and Disease: The parasites’ ability to evade the host’s immune system and adapt to different environments is crucial for their survival and transmission . Understanding the life cycle stages and mechanisms of immune evasion can inform the development of effective interventions to prevent and treat malaria .